A process for preparing a polydiene, the process comprising the step of: polymerizing conjugated diene monomer in the presence of a (hydrocarbyloxyhydrocarbyl)amine, where said step of polymerizing employs a lanthanide-based catalyst system.
US5631401A
申请人:——
公开号:US5631401A
公开(公告)日:1997-05-20
US9000107B2
申请人:——
公开号:US9000107B2
公开(公告)日:2015-04-07
[EN] CYCLOBUTANE DERIVATIVES AND THEIR USE AS INHIBITORS OF PROTEIN FARNESYLTRANSFERASE AND SQUALENE SYNTHASE<br/>[FR] DERIVES DU CYCLOBUTANE, LEUR UTILISATION COMME INHIBITEURS DE LA FARNESYL-TRANSFERASE PROTEIQUE ET DE LA SQUALENE-SYNTHASE
申请人:ABBOTT LABORATORIES
公开号:WO1995021815A1
公开(公告)日:1995-08-17
(EN) The present invention provides a compound of formula (I) or a pharmaceutically acceptable salt thereof, which are useful in inhibiting protein farnesyltransferase and the farnesylation of the oncogene protein Ras or inhibiting $i(de novo) squalene production resulting in the inhibition of cholesterol biosynthesis, processes for the preparation of the compounds of the invention in addition to intermediates useful in theses processes, a pharmaceutical composition, and to methods of using such compounds.(FR) La présente invention décrit un composé de formule (I) ou un sel pharmaceutiquement acceptable de ce composé, permettant d'inhiber la farnésyl-transférase protéique et la farnésylation de la protéine oncogène Ras ou d'inhiber la production $i(de novo) de squalène, ce qui a pour effet d'inhiber la biosynthèse du cholestérol. L'invention décrit également les procédés de préparation de ces composés ainsi que les intermédiaires utiles dans ces procédés, une composition pharmaceutique et des procédés pour l'utilisation de ces composés.
Inhibitors of protein farnesyltransferase and squalene synthase
申请人:Abbott Laboratories
公开号:US05631401A1
公开(公告)日:1997-05-20
The present invention provides a compound of the formula ##STR1## or a pharmaceutically acceptable salt thereof, which are useful in inhibiting protein farnesyltransferase and the farnesylation of the oncogene protein Ras or inhibiting de novo squalene production resulting in the inhibition of cholesterol biosynthesis, processes for the preparation of the compounds of the invention in addition to intermediates useful in these processes, a pharmaceutical composition, and to methods of using such compounds.